Ground-breaking evidence-based information on myopia management is now accessible to all eyecare practitioners (ECPs) around the world, following the release of the 2021 IMI White Papers Clinical Summaries in English and 12 other languages. The single page summaries are presented in easy to understand language.
They come following the highly anticipated second volume of the 2021 IMI White Papers and yearly digest, published in a special issue of the peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal.
More than 134 world-leaders in myopia contributed to the white papers, which provide updates for regions where the knowledge that we can prevent and slow myopia has not yet reached or remains in its infancy.
“We are excited to continue to bring the latest, evidence-based information directly to all ECPs across the world, by making this information easily understandable and accessible, through working with our incredible taskforce leaders and teams, translators and industry supporters,” said IMI Executive Director, Dr Monica Jong.
The IMI White Papers are among the top 2% of cited work, driving discussion, informing policy, and progressively advancing research, patient management and education in myopia to prevent future vision impairment and blindness associated with increasing myopia. The IMI white papers volume one and two and the latest single page clinical summaries are available in English and twelve international languages including Chinese, Vietnamese, Turkish, Spanish, French, Russian, German and Dutch. They are available at myopiainstitute.org/ imi-white-papers.